Wednesday - ARVO

Wednesday – Posters – 4619 – 4641
4619 — A0170 A novel Erythropoietin-derived
peptide regulates Endothelial Progenitor Cell
(EPC) mediated retinal vasorepair. Olivia E.
O’Leary 1 , E. Reid 1 , C. M. McVicar 1 , M. Brines 2 , A.
Cerami 2 , R. J. Medina 1 , D. P. Brazil 1 , A. W. Stitt 1 .
1
Centre for Vision and Vascular Science, Queen’s
University Belfast, Belfast, United Kingdom;
2
Warren Pharmaceuticals, Ossining, NY *CR
4620 — A0171 Effect of HMG-CoA reductase
inhibitor(statins) on the expression of catalase
in human retinal pigment epithelial cells. Min
Gu Kang, S. Lee, N. Kim, H. Chin. Department
of Ophthalmology and Inha Vision Science
Laboratory, Inha University School of Medicine,
Incheon, Republic of Korea
4621 — A0172 Resveratrol suppresses the
VEGF expression by inhibition of the CXCR4
Expression in ARPE-19 cells. Inyoung Chung 1 , H.
Seong 2 , S. Kang 2 , J. Park 1 , S. Seo 1 . 1 Ophthalmology,
School of Medicine, Institute of Health Sciences,
Gyeongsang National University, Jinju-si,
Republic of Korea; 2 Anatomy and Neurobiology,
School of Medicine, Institute of Health Sciences,
Medical Research Center for Neural Dysfunction,
Gyeongsang National University, Jinju-si, Republic
of Korea
4622 — A0173 Antiangiogenic Effect of
Quercetin on Laser-Induced Choroidal
Neovascularization in Mice. Junichi Fukuhara 1, 2 ,
K. Noda 1, 2 , S. Takashina 1, 2 , Y. Dong 1, 2 , S.
Kinoshita 1, 2 , Z. Dong 1, 2 , R. Ando 1, 2 , A. Kanda 1, 2 ,
S. Ishida 1, 2 . 1 Laboratory of Ocular Cell Biology
and Visual Science, Hokkaido University Graduate
School of Medicine, Sapporo, Japan; 2 Department
of Ophthalmology, Hokkaido University Graduate
School of Medicine, Sapporo, Japan
4623 — A0174 Genistein Suppresses Laser-
Induced Choroidal Neovascularization in Mice.
Satoshi Kinoshita 1, 2 , K. Noda 1, 2 , S. Takashina 1, 2 ,
Y. Dong 1, 2 , J. Fukuhara 1, 2 , Z. Dong 1, 2 , R. Ando 1, 2 ,
A. Kanda 1, 2 , S. Ishida 1, 2 . 1 Laboratory of Ocular
Cell Biology and Visual Science, Hokkaido
University Graduate School of Medicine, Sapporo,
Japan; 2 Department of Ophthalmology, Hokkaido
University Graduate School of Medicine, Sapporo,
Japan
4624 — A0175 Inhibition of Laser-induced
Choroidal Neovascularization by Macrolactin
Compounds. Sang Jin Kim 1 , J. Kim 1 , D. Kim 2 .
1
Ophthalmology, Samsung Medical Center,
Sungkyunkwan University School of Medicine,
Seoul, Republic of Korea; 2 Research and
Development Center, Daewoo Pharm. Co. Ltd.,
Busan, Republic of Korea *CR
4625 — A0176 Inhibition of choroidal
neovascularization by neutralizing PDGF with
a recombinant fusion protein of PDGFR β
domain. Yiwen Li 1 , W. Tao 2 , V. Ling 2 , A. Nystuen 2 ,
S. A. Elliott 2 , P. Stabila 2 , R. Wen 1 . 1 Bascom Palmer
Eye Institute, University of Miami, Miami, FL;
2
Neurotech USA, Lincoln, RI *CR
4626 — A0177 One-year Results of Intravitreal
Ranibizumab Combined with Reduced-Fluence
Photodynamic Therapy for Polypoidal Choroidal
Vasculopathy. Daisuke Yamanouchi, M. Sakurai,
T. Baba, M. Kitahashi, H. Yokouchi, M. Kubota-
Taniai, S. Yamamoto. Chiba univercity, Chiba, Japan
4627 — A0178 NIPAAm Based Cell Delivery
Scaffolds for Posterior Segment Therapeutics.
Ben Muirhead 1 , S. D. Fitzpatrick 1 , K. Gregory-
Evans 2 , M. Bhatia 1 , H. Sheardown 1 . 1 Biomedical
Engineering, McMaster University, Elmira, ON,
Canada; 2 Ophthalmology and Visual Sciences,
University of British Columbia, Vancouver, BC,
Canada *CR
Exhibit Hall B0092-B0137
Wednesday, May 08, 2013 11:00 AM-12:45 PM
Physiology/Pharmacology / Retinal Cell Biology
438 Retinal Flow and VEGF
Moderators: Michele Reibaldi and Tonia S. Rex
4628 — B0092 Subfoveal Choroidal blood
flow in senescence. John V. Lovasik, H. Kergoat,
M. Parent. School of Optometry, University of
Montreal, Montreal, QC, Canada
4629 — B0093 Time-dependent intracellular
pattern of Bevacizumab in RPE cells. Shereen
Hassan M. Aboul Naga 1, 2 , M. Dithmer 1 , J. Roider 1 ,
A. K. Klettner 1 . 1 Ophthalmology, University of
Kiel, University Medical Centre, Kiel, Germany;
2
Ophthalmology, Kasr Al Aini, Cairo University
Hospitals, Cairo, Egypt *CR
4630 — B0094 Antagonism of PDGFRβ
Inhibits Pericyte Recruitment in a Mouse Model
of Corneal Neovascularization. Amy Jensen 1 , R.
Cepeda 1 , M. Maker 1 , C. E. Bigelow 1 , J. Ghosh 1 ,
G. Li 1 , P. A. D’Amore 2 , G. Spohn 1 , B. D. Jaffee 1 , S.
Azarian 1 . 1 Ophthalmology, Novartis, Cambridge,
MA; 2 Ophthalmology, Schepens Eye Research
Institute, Boston, MA *CR
4631 — B0095 Dynamic retinal venous
oscillations are changed in diabetes mellitus
type 1. Konstantin E. Kotliar 1, 2 , I. M. Lanzl 2 , T.
Siegmund 4 , A. Schmidt-Trucksaess 5, 3 . 1 Biomedical
Engineering, Aachen University of Applied
Sciences, Juelich, Germany; 2 Ophthalmology,
Munich University of Technology, Munich,
Germany; 3 Preventive Sports Medicine, Munich
University of Technology, Munich, Germany;
4
Endocrinology and Diabetes, Bogenhausen
Hospital, Munich, Germany; 5 Division of Sports
Medicine, University of Basel, Basel, Switzerland
*CR
4632 — B0096 Parameters related to Choroidal
thickness. Yasuki Ito 1 , K. Oiwa 1 , E. Iwata 1 , A.
Takahashi 1 , T. Yasuma 1 , K. Kawano 1 , N. Hamajima 2 ,
H. Terasaki 1 . 1 Ophthalmology, Nagoya University
Graduate School of Medicine, Nagoya, Japan;
2
Department of Preventive Medicine, Nagoya
University Graduate School of Medicine, Nagoya,
Japan
4633 — B0097 Blockade of PGF/VEGFR1
signaling significantly prevents BRB breakdown,
apoptosis and inflammation in diabetic
retinopathy. Hu Huang, D. Johnson, D. Kim, G. A.
Lutty. Ophthalmology, Johns Hopkins Wilmer Eye
Inst, Baltimore, MD
f Refer to the Program Number in the Clinical Trial (CT) Registration Index. *CR Refer to the Program Number in the Commercial Relationships (CR) Index for Disclosures.
301
4634 — B0098 Computational Model of
Oxygen Transport in Retina and Optic Nerve.
David Bragason 1 , E. Stefánsson 1, 2 . 1 Ophthalmology,
Landspitali University Hospital, Reykjavik, Iceland;
2
Medicine, University of Iceland, Reykjavik,
Iceland *CR
4635 — B0099 Increased Retinal Vascular
Tortuosity in Obstructive Sleep Apnea. Amir
Mohsenin 1 , V. Mohsenin 2 , R. A. Adelman 1 .
1
Department of Ophthalmology, Yale University
School of Med, New Haven, CT; 2 Yale Center
for Sleep Medicine, Yale University School of
Medicine, New Haven, CT
4636 — B0100 Oxygen saturation in
retinal hemorrhages. Olafur Palsson 1, 2 , S. H.
Hardarson 1, 2 , T. S. Eliasdottir 2 , E. Stefánsson 1, 2 .
1
Department of Ophthalmology, Landspítali
University Hospital, Reykjavik, Iceland; 2 University
of Iceland, Reykjavik, Iceland *CR
4637 — B0101 Assessment of Total Retinal
Blood Flow under Systemic Hypercapnia
and Hypocapnia. Ayda M. Shahidi 1 , S. R.
Patel 1 , J. G. Flanagan 1, 3 , O. Tan 2 , D. Huang 2 , C.
Hudson 1, 3 . 1 Ophthalmology & Vision Science,
University Health Network, Toronto, ON, Canada;
2
Ophthalmology, Oregon Health and Science
University, Portland, OR; 3 Optometry & Vision
Science, University of Waterloo, Waterloo, ON,
Canada *CR
4638 — B0102 One-year results of
Central Retinal Sensitivity in eyes treated
with Pegaptanib for Proliferative Diabetic
Retinopathy with extended dosing. Blanca C.
Flores, V. H. Gonzalez, R. Diaz-Rohena. Valley
Retina Institute, McAllen, TX *CR, f
4639 — B0103 Persistent hyaloid vessels
counteract insufficient retinal perfusion in the
mouse eye. Christina Seide, M. Garcia Garrido,
V. Sothilingam, N. Tanimoto, S. C. Beck, M. W.
Seeliger. Div of Ocular Neurodegeneration, Ctr for
Ophthal Inst for Ophth Rsrch, Tuebingen, Germany
4640 — B0104 Retinal Vessel Diameter at
High Altitude. Gabriel Willmann 1 , A. Schatz 1 , M.
Fischer 1, 3 , K. Schommer 2 , E. Zrenner 1 , K. Bartz-
Schmidt 1 , F. Gekeler 1 . 1 Centre for Ophthalmology,
University of Tübingen, Tübingen, Germany;
2
Department of Sports Medicine, University
Hospital Heidelberg, Heidelberg, Germany;
3
Nuffield Laboratory of Ophthalmology, University
of Oxford, Oxford, United Kingdom *CR
4641 — B0105 Retinal and Cerebral
Oxygenation Response to Graded Hypoxia.
Sunni R. Patel 1 , C. Hudson 2, 3 , A. M. Shahidi 1 ,
S. Kulasekara 2 , J. Fisher 4 , J. G. Flanagan 2, 3 , W.
Mutch 5 . 1 Ophthalmology and Vision Sciences,
Toronto Western Hospital, Toronto, ON, Canada;
2
Department of Ophthalmology and Vision
Science, University of Toronto, Toronto, ON,
Canada; 3 School of Optometry and Vision Science,
University of Waterloo, Toronto, ON, Canada;
4
School of Physiology, University of Toronto,
Toronto, ON, Canada; 5 Perioperative Medicine
and Anaesthesiology, University of Manitoba,
Winnepeg, MB, Canada *CR
Wednesday Posters
11:00 am – 12:45 pm